A 12-month Prospective Observational Study Assessing the Real-world Clinical Effectiveness, Safety and Health-economic Benefits of Toujeo® Initiation After Oral Antidiabetic Drug Failure in Insulin-naïve Patients With Type 2 Diabetes Mellitus
A 12-month Prospective Observational Study Assessing the Real-world Clinical Effectiveness, Safety and Health-economic Benefits of Toujeo® Initiation After Oral Antidiabetic Drug Failure in Insulin-naïve Patients With Type 2 Diabetes Mellitus
Primary Objective:
Assess effectiveness of insulin glargine (U300) in achieving glycemic goal measured by hemoglobin A1c (HbA1c).
Secondary Objectives:
Patients will be observed for one year
Inclusion criteria :
Exclusion criteria:
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Portsaeid, Egypt
Bhabaneswar, 751012, India
Hyderabd, India
Al Jabriya, Kuwait
Al Jabriya, Kuwait
Airport Road, Lebanon
Bir Al Abed, Lebanon
Chtoura, Lebanon
Corniche El Mazraa, Lebanon
Hadath, Lebanon
Jal El Baher, Lebanon
Metn, Lebanon
Mount Lebanon, Lebanon
Dasmarinas Cavite, 4114, Philippines
Al Ehsa, Saudi Arabia
Kaohsiung Hsien,, Taiwan